Serum LOXL2 levels between the patients with HCC and those without HCC were not statistically different in Table 2; however, when utilizing the most suitable cut-off value calculated from the ROC curve for predicting HCC, serum LOXL2 level was found to be a significant predictive factor (Table3). Here, LOXL2 is linked to hepatocellular carcinoma.